Navigation Links
INTERPHEX and Parenteral Drug Association Announce Agreement
Date:8/19/2013

NORWALK, Conn., Aug. 19, 2013 /PRNewswire-USNewswire/ -- International Pharmaceutical Expo (INTERPHEX), the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry and the Parenteral Drug Association (PDA) are pleased to announce a three-year Sponsorship Agreement.  This Sponsorship aligns the objectives of both organizations to service key needs of the global pharmaceutical and biopharmaceutical industry by driving innovation and advancement.

(Logo: http://photos.prnewswire.com/prnh/20130226/DC66667LOGO)

INTERPHEX serves as a strong platform for decision-makers in the pharmaceutical and biopharmaceutical manufacturing community, bringing together over 12,000 industry professionals to learn, network and source from the latest technology, equipment, education and services. PDA is the premier global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical industry. Its mission is to develop scientifically sound, practical technical information and resources to advance science and regulation for the pharmaceutical and biopharmaceutical industry through the expertise of its more than 9,500 global members.

"Our Sponsorship of INTERPHEX reflects our support of the continued enhancement of industry learning and improvement, areas we find present at INTERPHEX," stated Richard Johnson, President and CEO of PDA. "Non-profits and corporate entities can work together to leverage best practices, in real-time, to the benefit of our industry. Our collaboration with INTERPHEX is one example of this effort and we are pleased to move forward in this shared endeavor."

PDA will be directly involved in developing the INTERPHEX conference programming identifying speakers from industry and regulatory agencies and developing a PDA sponsored cGMP Track.  PDA members will have extensive educational and networking opportunities including an exclusive Association Membership Lounge.

"A long-term Sponsorship with PDA, both on national and global levels, aligns us with thought leaders across the globe," stated Bob Stewart, Vice President of INTERPHEX. "By fostering alliances with successful non-profit organizations like PDA, we acknowledge our investment in the future of the biopharmaceutical industry, and ultimately deliver unrivaled opportunities for knowledge, interaction, and professional growth."

INTERPHEX will be held March 18-20, 2014 at the Jacobs Javits Center in New York City, NY

About INTERPHEX
International Pharmaceutical Expo (INTERPHEX) is the world's most trusted forum for leading-edge technology, education and sourcing of equipment, products and services that improve manufacturing and supply chain performance for pharmaceutical, biologic, generic and service provider professionals. It brings pharmaceutical and biotechnology professionals together with suppliers through a unique combination of conference, exhibition, workshops, partnering opportunities, and networking events. For information, visit www.INTERPHEX.com and follow INTERPHEX on Facebook, LinkedIn and Twitter (@INTERPHEX.)

About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. PDA's Annual Meeting will be held April 7-9, 2014 in San Antonio, Texas. For information, visit www.pda.org and follow PDA on LinkedIn.

Press Contacts:
Lauren Laramore
Director of Marketing, INTERPHEX
T: 203-840-5958
Email: llaramore@reedexpo.com

Amelia Townsend
Director of Marketing Services, Parenteral Drug Association® (PDA)
T: 301-656-5900, ext. 153
Email: townsend@pda.org


'/>"/>
SOURCE Parenteral Drug Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Xyntek-Antares & ESS Technologies to Unveil New Ultra Compact TaskMate(R) Robotic Case Erector / Loader with Track & Trace at Interphex 2013
2. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
3. Pharmagen to Present Strategic Vision for Solving Nations Parenteral Drug Shortage Crisis at 2013 BIO International Convention
4. AAIPharma Appoints Senior Director of Parenteral Operations
5. Cepheid Launches Mobile Community for Ride Against TB Campaign to Benefit the American Lung Association
6. West Virginia Retailers Association praises NPLEx
7. West Virginia Retailers Association Highlights Success Of NPLEx In Battle Against Meth Labs
8. Linde Distributor Association, at twenty, is a leading buying group in the U.S.
9. Henry Schein Chairman Of The Board & CEO Receives Centennial Recognition Award For Extraordinary Commitment To The National Dental Association
10. Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo
11. Cepheid and American Lung Association Partner for Tuberculosis Awareness in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):